Overview

Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics, safety, tolerability and food effect of investigational drug MRX1 in healthy adults.
Phase:
PHASE1
Details
Lead Sponsor:
Tiamat Australia Pty Ltd
Collaborator:
Ananda Pharma plc
Treatments:
Cannabidiol